Continuing our rapid growth in 2019, Restech | Mederi-RF is pleased to announce a distribution agreement with Innovamedica S.P.A.
With a decade of experience with the Secca and Stretta product lines, and a 20 year history of providing comprehensive coverage in the gastroenterology marketplace, Innovamedica provides the ideal platform for the rapid growth of Restech diagnostic products in the Italian market.
Restech has a long tradition of supplying key opinion leaders in Italy with diagnostic devices, and with this new agreement seeks to expand in the therapeutic sector.
“Italy is a key global market,” said Debra Krahel, CEO of Restech, “With Innovamedica, we are confident that we can provide excellent customer and clinical care, and continued product growth. We are gaining an essential partner as Restech continues to expand.”
INNOVAMEDICA is a 100% private, independent and Italian company that has been in operation since 1999. Their focus is in the distribution of specialty medical devices, including minimally invasive and mechanical surgery, digestive endoscopy and enteral nutrition, urogynaecology, and endourology. INNOVAMEDICA prides itself as an innovative partner in these specialties, supporting medical devices that combine quality and cutting-edge technology at affordable prices.
Restech | Mederi-RF provides safe and effective minimally invasive solutions for reflux diagnosis and treatment; along with fecal incontinence therapy. Our diagnostic line features the only clinic-based pH monitoring system with a sensor capable of measuring pH in aerosolized refluxate in the oropharynx and esophagus. Holding over 100 patents, Restech utilizes engineering excellence to improve diagnostic accuracy and sensitivity.
Our non-surgical, non-ablative radiofrequency (RF) therapies for GERD, LPR, and fecal incontinence improve sphincter muscle function for lasting results. Key products include the Dx-pH Monitoring System (for reflux diagnosis); and the Stretta and Secca RF therapeutic systems (for reflux and bowel incontinence treatment, respectively).
Would you like to learn more? Please contact us or call 1.858.673.3700.